ELAC2 Gene Prostate Cancer Hereditary Type 2 Susceptibility to Genetic Test sale cost 4400 AED
SDHD Gene Paraganglioma and Gastric Stromal Sarcoma Genetic Test sale cost 4400 AED SDHD Gene Paraganglioma and Gastric Stromal Sarcoma Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Cancer Targeted Gene Panel CNS Tumor Test sale cost 4680 AED Cancer Targeted Gene Panel CNS Tumor Test Cost 5,200 د.إ Original price was: 5,200 د.إ.4,680 د.إCurrent price is: 4,680 د.إ.
Sale!

ELAC2 Gene Prostate Cancer Hereditary Type 2 Susceptibility to Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ELAC2 gene, associated with Hereditary Prostate Cancer Type 2, plays a significant role in understanding the genetic predisposition to prostate cancer. This gene, when mutated, increases the risk of developing prostate cancer, marking its importance in genetic testing for individuals with a family history of the condition. DNA Labs UAE offers a specialized genetic test aimed at identifying mutations in the ELAC2 gene, providing valuable insights into an individual’s susceptibility to hereditary prostate cancer type 2.

This test is crucial for early detection and preventive measures, offering a proactive approach to managing the risk of prostate cancer. Priced at 4400 AED, the test is conducted with precision and confidentiality, ensuring individuals receive comprehensive support and information regarding their genetic health. By understanding one’s genetic predisposition through the ELAC2 gene test, individuals can make informed decisions about their health, potentially leading to early intervention and tailored treatment strategies.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ELAC2 Gene Prostate Cancer Hereditary Type 2 Susceptibility to Genetic Test

Welcome to DNA Labs UAE, where we offer the ELAC2 Gene Prostate Cancer Hereditary Type 2 Susceptibility to Genetic Test. This test can help determine an individual’s susceptibility to hereditary type 2 prostate cancer and provide important information for personalized treatment and screening recommendations.

Test Details

The ELAC2 gene is a gene that encodes the enzyme RNase Z, which is involved in the processing of transfer RNA (tRNA) molecules. Mutations in the ELAC2 gene have been associated with an increased risk of developing prostate cancer, particularly hereditary type 2 prostate cancer.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or even the entire genome. It can identify mutations or variations in the ELAC2 gene and other genes associated with prostate cancer.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Cancer
  • Doctor: Oncologist
  • Test Department: Genetics

Pre Test Information

Before undergoing the ELAC2 Gene Prostate Cancer Hereditary Type 2 Susceptibility to Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with ELAC2 Gene Prostate Cancer, hereditary type 2, susceptibility to NGS Genetic DNA Test gene ELAC2.

Please note that genetic testing for prostate cancer susceptibility is typically recommended for individuals with a family history of the disease or those who meet certain clinical criteria. A genetic counselor or healthcare provider can help determine if NGS genetic testing for ELAC2 and other genes associated with prostate cancer is appropriate for an individual.

For more information or to schedule a test, please contact our Genetics Test Department.

Test Name ELAC2 Gene Prostate cancer hereditary type 2 susceptibility to Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cancer
Doctor Oncologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ELAC2 Gene Prostate cancer, hereditary type 2, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ELAC2 Gene Prostate cancer, hereditary type 2, susceptibility to NGS Genetic DNA Test gene ELAC2
Test Details

The ELAC2 gene is a gene that encodes the enzyme RNase Z, which is involved in the processing of transfer RNA (tRNA) molecules. Mutations in the ELAC2 gene have been associated with an increased risk of developing prostate cancer, particularly hereditary type 2 prostate cancer.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or even the entire genome. It can identify mutations or variations in the ELAC2 gene and other genes associated with prostate cancer. This type of testing can help determine an individual’s susceptibility to hereditary type 2 prostate cancer and provide important information for personalized treatment and screening recommendations.

It is important to note that genetic testing for prostate cancer susceptibility is typically recommended for individuals with a family history of the disease or those who meet certain clinical criteria. A genetic counselor or healthcare provider can help determine if NGS genetic testing for ELAC2 and other genes associated with prostate cancer is appropriate for an individual.

SKU: TEST-4575 Category:

Related products